Baseline drug resistance mutations are detectable in HCV genes NS3 and NS5A but not NS5B in acute and chronic HIV-coinfected patients

A.L. McCormick, L. Moynihan, M.J. Macartney, A. Garcia-Diaz, C. Smith, M.A. Johnson, A.J. Rodger, S. Bhagani, T. Haque, D.P. Webster

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)361-363
Number of pages3
JournalAntiviral Therapy
Volume20
Issue number3
DOIs
Publication statusPublished - 3 Oct 2014

Keywords

  • Science & Technology
  • Life Sciences & Biomedicine
  • Infectious Diseases
  • Pharmacology & Pharmacy
  • Virology
  • ACUTE HEPATITIS-C
  • VIRUS GENOTYPE 1
  • NATURAL POLYMORPHISMS
  • DECREASED SENSITIVITY
  • PROTEASE INHIBITORS
  • INFECTION
  • VARIANTS
  • TRIAL
  • PREVALENCE
  • TELAPREVIR

Cite this